All > Neuroendocrine Tumor

68Ga -DOTATATE PET scans for Neuroendocrine Tumors

Princess Margaret Cancer Centre, Toronto, Canada
Neuroendocrine Tumors68Ga -DOTATATE PET scans - DiagnosticTest
Eligibility
Any Age
All Sexes

Study Summary

This trial is testing whether PET scans using 68Ga-DOTATATE can help manage neuroendocrine tumours by seeing if the scans change how patients are treated.

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
[68Ga]Pentixafor
1
Gallium Dotatate
1
Peposertib

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 5 years

5 years
Number of participants for whom the intended clinical management prior to PET is changed after 68Ga-DOTATATE PET.

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
[68Ga]Pentixafor
1
Gallium Dotatate
1
Peposertib

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

68Ga -DOTATATE PET scan
1 of 1

Experimental Treatment

2000 Total Participants · 1 Treatment Group

Primary Treatment: 68Ga -DOTATATE PET scans · No Placebo Group · N/A

68Ga -DOTATATE PET scan
DiagnosticTest
Experimental Group · 1 Intervention: 68Ga -DOTATATE PET scans · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,396 Previous Clinical Trials
472,363 Total Patients Enrolled
5 Trials studying Neuroendocrine Tumors
770 Patients Enrolled for Neuroendocrine Tumors
Ur Metser, M.D.Principal InvestigatorPrincess Margaret Cancer Centre

Eligibility Criteria

Age Any Age · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The study is for patients with NET who need help finding where their disease is and how much it has spread, so doctors can plan the best treatment.
If you have a type of cancer called NET and your doctors are considering surgery or a type of radiation called PRRT, or if traditional imaging has not provided a clear picture of your cancer when it has progressed, you may be eligible for the study.
References

Frequently Asked Questions

What is the enrollment capacity of this scientific experiment?

"Affirmative. Records on clinicaltrials.gov state that this medical study, initially posted on March 28th 2019, is still recruiting patients. From one location, 2000 individuals are needed to participate in the trial." - Anonymous Online Contributor

Unverified Answer

Are there any open spots in this research endeavor?

"According to the clinicaltrials.gov listing, this medical trial is still actively recruiting participants since its initial post on March 28th 2019 and most recent update on November 25th 2021." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top